Sachin R. Atre, PhD

Pune, India
Role: 
Staff
Study Coordinator
Sachin R. Atre, PhD

Sachin Atre is a medical anthropologist who has 18 years of experience in public health research. Since November 2015, he has served as the Study Coordinator for the study Impact of Diabetes on TB Treatment Outcomes, funded by NIH/NIAID funded project on “Impact of Diabetes on TB Treatment Outcomes” which is in collaboration with Johns Hopkins University USA, BJ Medical College, India and Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune, India. He played a key role in setting up a new study site at Dr. D.Y. Patil Medical College, Hospital and Research Centre and currently coordinates activities there. Additionally, he also helps to coordinate activities for miDOT, which is testing video-based observation of treatment among TB patients. He also led efforts in setting up infection control measures (implementation of Ultra Violet Germicidal Irradiation, shortly known as UVGI) at BJ Medical College Pune.

Dr. Atre has received a PhD from the University of Pune and his doctoral research work was focused on understanding biosocial determinants of drug-resistant TB among patients in urban and rural areas of Maharashtra. During Sept. 2013-Sept. 2014, he was awarded with Fulbright-Nehru Post doc Fellowship at the Department of Global Health and Social Medicine at Harvard Medical School. The work at Harvard was focused on addressing policy needs for multidrug-resistant TB management and control in India involving a systematic review of studies on MDR-TB prevalence in India. The policy paper based on this work has been listed among the most influential articles recommended by Springer-Nature group journal editors. After returning from Harvard, Dr. Atre served as an independent technical consultant for the Global TB Program of the World Health Organization during 2014-15. The work involved a literature review and documentation of mandatory TB notification policies and practices among high, medium and low TB incidence countries especially to point out challenges in high TB incidence countries and to provide a guidance on how those can be tackled. It has been published in the European Respiratory Journal in December 2016. Dr. Atre is an academic collaborator for Global Burden of Disease (GBD) initiative led by Prof. Chris Murray.

Before going to Harvard on Fulbright fellowship, Dr. Atre has worked with the Foundation for Research in Community Health (FRCH) for 12 years and for a half year for Maharashtra Association of Anthropological Sciences-Centre for Health Research and Development (MAAS-CHRD). His work encompassed a wide range of areas such as tuberculosis, diabetes, access to medicines, ageing, nutrition, leprosy, family planning etc. which have cross-cutting interests of social sciences and public health. He also served for a consulting firm at New Delhi on two different projects, one focusing on ‘IDRC’s (Canada) Strategic Evaluation of Research Excellence,’ and the other an evaluation of the ‘Awahan Project’ funded by the Gates Foundation.

Dr. Atre has presented his work at international conferences and/meetings in 12 countries. He has served as an invited reviewer for reputed journals such as WHO Bulletin, The Lancet Global Health, PLoS One, International Journal of TB and Lung Disease and BMC Public Health etc. Dr. Atre has contributed in about 25 publications in peer-reviewed international journals and in majority of them he is the lead author.

miDOT (Directly Observed Therapy)

Post Date: 
2015-11-01
Designed by Dr. Maunank Shah, the miDOT mobile health application is a video-based Directly Observed Therapy interface that uses the emocha Mobile Health platform to remotely connect patients on long-term tuberculosis therapy with clinicians who are required to witness patients taking medication...

Impact of Diabetes on TB Treatment Outcomes

Post Date: 
2013-02-01
Country: 
CCGHE, the JHU Center for TB Research and BJGMC have been awarded a $2.5 million dollar NIH grant (2013-2018) to conduct a study to evaluate treatment outcomes among Indian patients with both diabetes mellitus and active TB. This study is assessing the prevalence of impaired glucose or frank...

Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016

Post Date: 
2017-09-16
Publication: 
The Lancet
Abstract Background: Detailed assessments of mortality patterns, particularly age-specific mortality, represent a crucial input that enables health systems to target interventions to specific populations. Understanding how all-cause mortality has changed with respect to development status can...

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

Post Date: 
2017-09-16
Publication: 
The Lancet
Abstract Background: As mortality rates decline, life expectancy increases, and populations age, non-fatal outcomes of diseases and injuries are becoming a larger component of the global burden of disease. The Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) provides a...

Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016

Post Date: 
2017-09-12
Publication: 
The Lancet
Abstract Background: The UN's Sustainable Development Goals (SDGs) are grounded in the global ambition of "leaving no one behind". Understanding today's gains and gaps for the health-related SDGs is essential for decision makers as they aim to improve the health of populations. As part of the...

Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: a novel analysis from the Global Burden of Disease Study 2015

Post Date: 
2017-07-15
Publication: 
The Lancet
Abstract Background: National levels of personal health-care access and quality can be approximated by measuring mortality rates from causes that should not be fatal in the presence of effective medical care (ie, amenable mortality). Previous analyses of mortality amenable to health care only...

A qualitative study exploring factors influencing clinical decision-making for influenza-like illness in Solapur city, Maharashtra, India

Post Date: 
2017-07-03
Publication: 
Anthropology and Medicine
Country: 
Abstract The co-existence of different types of medical systems (medical pluralism) is a typical feature of India's healthcare system. For conditions such as influenza-like illness (ILI), where non-specific disease signs/symptoms exist, clinical reasoning in the context of medical pluralism becomes...

The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

Post Date: 
2017-03-24
Publication: 
The Lancet Respiratory Medicine
Global tuberculosis incidence has declined marginally over the past decade, and tuberculosis remains out of control in several parts of the world including Africa and Asia. Although tuberculosis control has been effective in some regions of the world, these gains are threatened by the increasing...

Modelling approaches for tuberculosis: are they realistic?

Post Date: 
2017-03-01
Publication: 
The Lancet Global Health
Country: 
Letter by Dr. Sachin Atre in The Lancet Global Health.

Tuberculosis burden in India's private sector

Post Date: 
2016-11-15
Publication: 
The Lancet Infectious Disease
Country: 
Reply to author's reply

Mandatory tuberculosis case notification in high tuberculosis-incidence countries: policy and practice

Post Date: 
2016-10-20
Publication: 
European Respiratory Journal
Mandatory tuberculosis (TB) notification is an important policy under the End TB Strategy, but little is known about its enforcement especially in high TB incidence countries. We undertook a literature search for selected high-incidence countries, followed by a questionnaire-based survey among key...

Management and control of multidrug-resistant tuberculosis (MDR-TB): addressing policy needs for India

Post Date: 
2016-05-06
Publication: 
Journal of Public Health Policy
Country: 
Multidrug-resistant tuberculosis (MDR-TB) challenges TB control efforts because of delays in diagnosis plus its long-term treatment which has toxic effects. Of TB high-incidence countries, India carries the highest burden of MDR-TB cases. We describe policy issues in India concerning MDR-TB...

Trends in Glycated Hemoglobin Levels and Implications for Diabetes Screening among Pulmonary Tuberculosis Cases Undergoing Treatment in India

Post Date: 
2017-09-13
Presentation Location: 
Rio de Janiero, Brazil
Country: 
Event & Convener: 
3rd Annual RePORT International Meeting, RICC
Poster Presentation. Gupte AN , Mave V, Meshram S, Lokhande R, Kadam D, Dharmshale S, Bharadwaj R, Kagal A, Pradhan N, Deshmukh S, Atre S, Sahasrabudhe T, Barthwal M, Meshram S, Kakrani A, Kulkarni V, Raskar S, Suryavanshi S, Shivakoti R, Chon S, Selvin E, Gupte N, Gupta A, Golub JE

Xpert® MTB/RIF Assay for Pulmonary Tuberculosis Diagnosis in Patients with Diabetes Mellitus

Post Date: 
2016-10-27
Presentation Location: 
Durban, South Africa
Event & Convener: 
47th Union World Conference on Lung Health. International Union for Tuberculosis and Lung Disease.
Poster Presentation. Mave V , Gupte N, Meshram S, Kagal A, Gupta A, Bharadwaj R, Pradhan N, Deshmukh S, Atre S, Golub J